Vis enkel innførsel

dc.contributor.authorThronæs, Morten
dc.contributor.authorRaj, Sunil
dc.contributor.authorBrunelli, Cinzia
dc.contributor.authorAlmberg, Sigrun Saur
dc.contributor.authorVagnildhaug, Ola Magne
dc.contributor.authorBruheim, Susanna
dc.contributor.authorHelgheim, Birgit
dc.contributor.authorKaasa, Stein
dc.contributor.authorKnudsen, Anne Kari
dc.date.accessioned2017-11-17T15:39:28Z
dc.date.available2017-11-17T15:39:28Z
dc.date.created2016-01-19T13:21:14Z
dc.date.issued2016
dc.identifier.citationSupportive Care in Cancer. 2016, 24 (6), 2565-2574.nb_NO
dc.identifier.issn0941-4355
dc.identifier.urihttp://hdl.handle.net/11250/2467031
dc.description.abstractPurpose: Cancer pain (CP) management is challenging. In recent years, efforts were undertaken to achieve better CP management, e.g. clinical research, new treatment modalities, development of guidelines, education, and focus on implementation. The aim of the present study was to compare the prevalence and characteristics of pain and breakthrough pain (BTP) between cross-sectional studies conducted in 2008 and 2014. It was hypothesized that an improvement in pain control would be observed the years in-between. Methods: Two cross-sectional studies were conducted where adult cancer patients answered questions from Brief Pain Inventory and the Alberta Breakthrough Pain Assessment Tool for cancer patients. Physicians reported socio-demographic and medical data. Regression models were applied for analysis. Results: In total, 168 inpatients, 92 in 2008 and 76 in 2014, and 675 outpatients, 301 in 2008 and 374 in 2014, were included. The patient characteristics of the samples were comparable. Prevalence of CP among inpatients was 55% in 2008 and 53% in 2014, and among outpatients 39% and 35%, respectively. Inpatients reported average pain intensity (0-10 NRS) of 3.60 (SD 1.84) (2008) and 4.08 (SD 2.11) (2014), prevalence of BTP was 52% (2008) and 41% (2014). For outpatients, average pain intensity was 3.60 (SD 2.04) (2008) and 3.86 (SD 2.20) (2014), prevalence of BTP was 43% (2008) and 37 % (2014). None of the differences were statistically significant. Conclusion: Unexpectedly, no improvement in pain control was observed. Efforts are still needed to improve cancer pain management.nb_NO
dc.language.isoengnb_NO
dc.publisherSpringernb_NO
dc.titleIs it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart.nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber2565-2574nb_NO
dc.source.volume24nb_NO
dc.source.journalSupportive Care in Cancernb_NO
dc.source.issue6nb_NO
dc.identifier.doi10.1007/s00520-015-3064-3
dc.identifier.cristin1317212
dc.description.localcode© Springer-Verlag Berlin Heidelberg 2015. This is the authors’ accepted and refereed manuscript to the article. The final publication is available at Springer via http://dx.doi.org/10.1007/s00520-015-3064-3nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel